Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

JOHNSON & JOHNSON ($JNJ) Releases Q2 2026 Earnings

None

JOHNSON & JOHNSON ($JNJ) posted quarterly earnings results for Q2 2026 on Wednesday, July 15th. The company reported earnings of $2.90 per share, beating estimates of $2.87 by $0.03. The company also reported revenue of $25,310,000,000, beating estimates of $25,299,221,875 by $10,778,125.

You can see Quiver Quantitative's $JNJ stock page to track data on insider trading, hedge fund activity, congressional trading, and more.

JOHNSON & JOHNSON Insider Trading Activity

JNJ Insider Trades

JOHNSON & JOHNSON insiders have traded $JNJ stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.

Here’s a breakdown of recent trading of $JNJ stock by insiders over the last 6 months:

  • JOAQUIN DUATO (CEO and Chairman of the Board) has made 0 purchases and 2 sales selling 100,000 shares for an estimated $22,122,893.
  • JOSEPH J WOLK (Exec VP, CFO) has made 0 purchases and 4 sales selling 89,654 shares for an estimated $21,767,826.
  • JAMES D. SWANSON (EVP, CIO) has made 0 purchases and 3 sales selling 62,080 shares for an estimated $15,109,758.
  • JOHN C REED (EVP, Innovative Medicine, R&D) has made 0 purchases and 3 sales selling 53,931 shares for an estimated $13,105,233.
  • TIMOTHY SCHMID (EVP, WW Chair, MedTech) has made 0 purchases and 3 sales selling 23,945 shares for an estimated $5,852,268.
  • KATHRYN E WENGEL (EVP, Chief TO and Risk Officer) sold 10,000 shares for an estimated $2,411,500
  • VANESSA BROADHURST (EVP, Global Corp Affairs) sold 6,197 shares for an estimated $1,508,287
  • ROBERT J DECKER (VP Corporate Controller) sold 4,075 shares for an estimated $1,010,070

To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.

JOHNSON & JOHNSON Hedge Fund Activity

We have seen 1,818 institutional investors add shares of JOHNSON & JOHNSON stock to their portfolio, and 2,067 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

  • AUTO-OWNERS INSURANCE CO removed 69,083,868 shares (-99.5%) from their portfolio in Q1 2026, for an estimated $16,851,282,501
  • HIGHTOWER ADVISORS, LLC added 6,535,453 shares (+165.5%) to their portfolio in Q1 2026, for an estimated $1,594,160,373
  • FMR LLC added 5,995,157 shares (+31.9%) to their portfolio in Q1 2026, for an estimated $1,462,368,671
  • CAPITAL RESEARCH GLOBAL INVESTORS added 5,870,178 shares (+204.5%) to their portfolio in Q1 2026, for an estimated $1,431,883,168
  • CAPITAL INTERNATIONAL INVESTORS removed 4,853,668 shares (-65.0%) from their portfolio in Q1 2026, for an estimated $1,183,930,966
  • BLACKROCK, INC. added 4,604,387 shares (+2.2%) to their portfolio in Q1 2026, for an estimated $1,123,125,098
  • DIAMANT ASSET MANAGEMENT, INC. added 4,454,778 shares (+24436.5%) to their portfolio in Q1 2026, for an estimated $1,086,631,723

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

JOHNSON & JOHNSON Government Contracts

We have seen $31,051,925 of award payments to $JNJ over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

JOHNSON & JOHNSON Congressional Stock Trading

Members of Congress have traded $JNJ stock 7 times in the past 6 months. Of those trades, 2 have been purchases and 5 have been sales.

Here’s a breakdown of recent trading of $JNJ stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

JOHNSON & JOHNSON Analyst Ratings

Wall Street analysts have issued reports on $JNJ in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Morgan Stanley issued a "Overweight" rating on 01/28/2026
  • TD Cowen issued a "Buy" rating on 01/22/2026

To track analyst ratings and price targets for JOHNSON & JOHNSON, check out Quiver Quantitative's $JNJ forecast page.

JOHNSON & JOHNSON Price Targets

Multiple analysts have issued price targets for $JNJ recently. We have seen 15 analysts offer price targets for $JNJ in the last 6 months, with a median target of $255.0.

Here are some recent targets:

  • Joanne Wuensch from Citigroup set a target price of $298.0 on 07/08/2026
  • Terence Flynn from Morgan Stanley set a target price of $284.0 on 07/08/2026
  • Vamil Divan from Guggenheim set a target price of $270.0 on 06/26/2026
  • David Risinger from Leerink Partners set a target price of $265.0 on 05/13/2026
  • Larry Biegelsen from Wells Fargo set a target price of $263.0 on 04/15/2026
  • Rick Wise from Stifel set a target price of $250.0 on 04/15/2026
  • Matt Miksic from Barclays set a target price of $255.0 on 04/15/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles